Updates
GENEGUT Synergies: Collaboration across GENEGUT partners advances development of RNA-based nanoparticles for oral delivery to treat Crohn’s disease
Collaboration between partners at Cork University and Uppsala University has resulted in a robust system to investigate the interactions between the NPs formulated and 3D ileal organoids, as well as monitoring delivery efficiency and intracellular trafficking.
RECAP: GENEGUT Seminar with Driton Vllasaliu, Engineered milk extracellular vesicles for oral delivery of RNA
RECAP: GENEGUT Seminar with Driton Vllasaliu, Engineered milk extracellular vesicles for oral delivery of RNA
New GENEGUT publication: Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease
We are happy to announce that our new GENEGUT publication “Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease” is now available to read online.
GENEGUT Seminar Series: Engineered milk extracellular vesicles for oral delivery of RNA | Dr. Driton Vllasaliu
We are excited to announce the first online seminar session in its upcoming series, featuring Dr. Driton Vllasaliu from King’s College London as a guest speaker. Dr. Vllasaliu will present
Patient stories: Over ten years to acceptance
I’ve lived with Crohn’s disease since I was nine years old, but it took me more than ten years to come to terms with my disease. At first, I was
GENEGUT highlights 2024
The GENEGUT project achieved numerous milestones in 2024. Download the brochure and read about the progress of GENEGUT: Brochure Watch this space and follow us on Twitter and LinkedIn for more project updates.
UK participants in Horizon Europe Project GENEGUT are supported by UKRI grant number 10042451 (Bangor University).